#GLP1Drugs #WeightLossScience #HealthHacks #Ozempic #Wegovy #PodcastMD About This Episode: Ozempic, Wegovy, MounjaroGLP-1 medications are everywhere
When semaglutide starts working Semaglutide delivers results on a dramatically compressed timeline
New Level II HCPCS Codes Final Rule Comment Solicitation Consistent with past practice, we are soliciting comments on the new Level II HCPCS codes that will be effective January 1, 2026, in the CY 2026 OPPS/ASC final rule with comment period, thereby allowing us to finalize the status indicators and APC assignments for the codes in the CY 2027 OPPS/ASC final rule with comment period
Where a technology sits on the scale depends in part on where the roadmap ends
1 LADA is a slow-progressing form of autoimmune diabetes
While often referred to as weight loss injections or skinny jabs, its important to note that not all GLP-1s are licensed for weight loss